Cancer: Specific targeting of tumour cells
Nature Communications
July 18, 2012

Cell-penetrating peptides that target particular lineages of tumour cells are described in a study published in Nature Communications this week. These agents could provide a good system for delivering anti-cancer molecules to tumour cells.
Cell-penetrating peptides have been previously described but little is known about their specificity for different tumour cell types. In this study, Eisaku Kondo and colleagues show that some cell-penetrating peptides only permeate one or two cell types in culture. Focusing on a peptide that targets leukemia cells in culture, they show that the peptide did not readily penetrate non-cancerous cells. However, they identified a transporter that may be important for uptake of peptides into this cell type. They also showed that a peptide attached to a known tumour suppressor enhanced the death of cells in culture and reduced metastasis of tumours in mice. These findings suggest that these peptides could be used to target specific tumour cell type.
doi: 10.1038/ncomms1952
Research highlights
-
Jan 13
Genetics: Correcting for genetic associations between alcohol and diseaseNature Communications
-
Dec 23
Biomedical engineering: Tiny device goes with the (blood) flowNature Communications
-
Dec 21
Epidemiology: Underdetection of COVID-19 after the first lockdown in FranceNature
-
Dec 18
Geology: Alpine summits may have been ice-free during life of Tyrolean IcemanScientific Reports
-
Dec 17
Epidemiology: Mapping gaps in measles vaccination coverageNature
-
Dec 17
Neuroscience: When you’re smiling, the whole world smiles with youNature